45 results
424B5
MRK
Merck & Co Inc
10 May 23
Prospectus supplement for primary offering
4:27pm
pandemic. One must carefully consider any such statement and should understand that many factors could cause actual results to differ materially from our … of the global COVID-19 pandemic and any future pandemic, epidemic, or similar public health threat, on the Company’s business, operations, financial
424B5
t6gr235b e85rn
8 May 23
Prospectus supplement for primary offering
8:17am
PX14A6G
r1ce91ib200x
21 Apr 23
Letter to shareholders
7:39pm
PX14A6G
040z09
19 Apr 23
Letter to shareholders
4:04pm
8-K
EX-99.1
kvof7lq
27 Oct 22
Merck Announces Third-Quarter 2022 Financial Results
6:38am
8-K
EX-99.1
l46q7yl
28 Jul 22
Merck Announces Second-Quarter 2022 Financial Results
6:36am
PX14A6G
0vj7sd v0wsh30
13 May 22
Letter to shareholders
2:32pm
8-K
EX-99.1
lnhz6
28 Apr 22
Merck Announces First-Quarter 2022 Financial Results
6:35am
424B5
uvknot 2zzd
9 Dec 21
Prospectus supplement for primary offering
4:37pm